Previous reports demonstrated that alloantigen- or xenoantigen-specifi
c antibodies displayed neutralizing activity toward human or simian im
munodeficiency viruses, In the present article we have addressed the q
uestion of alloantigen-induced cell-mediated anti-HIV activity, We sho
w that allostimulation resulted in a lymphocyte population (largely of
the CDS-positive phenotype) with the capacity to inhibit HIV-1 replic
ation in PHA blasts of homologous and, unexpectedly, also autologous o
rigin, The allostimulated effector cells exerted their activity via a
noncytolytic mechanism: Experiments in which direct cell-to-cell conta
ct between allostimulated effecters and HIV-1-infected PHA blasts was
prevented by a semipermeable membrane indicated that soluble mediators
were involved in inhibition of HIV-1 replication, As such allostimula
ted effecters not only would have the capacity to prevent viral replic
ation in allogeneic HIV-l-infected cells (known to play an important r
ole in HIV-1 transmission in vivo), but also might inhibit HIV-1 growt
h in autologous lymphocytes, the concept of an AIDS vaccine containing
both HIV-1 antigens and alloantigens warrants further consideration.